Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function.
CAS：1025504-45-3
分子式：C24H38N2O4
分子量：418.57
纯度：98%
存储：Store at -20°C

Background:

Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function.

Valbenazine shows a distinctive improvement in tardive dyskinesia symptoms during the successful Phase II trial[1].

参考文献:
[1]. Müller T, et al. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Expert Opin Investig Drugs. 2015 Jun;24(6):737-42.